Latest Insights - page 86 | BiopharmaTrend

What are the ADC drugs?

The antibody-drug conjugates (ADCs) market continues to rise globally, but ADCs are not a new thing. Why has ADC been surging for so many years? What kind of "magic" power it …

Continue ›››

Companies Driving Innovation To Fight Alzheimer’s Disease

The overall technological progress in medicine and the overall increase in the quality and safety of life, compared to even a century ago, led to a substantial growth of the …

Continue ›››

Alex Zhavoronkov: Linking Chemistry and Biology Using Artificial Intelligence

The team at Insilico Medicine has recently reported that they achieved a major milestone for their comprehensive artificial intelligence (AI)-based drug discovery system: a novel molecule for a novel target …

Continue ›››

Contract Research Organizations Tap Into AI To Increase Value Proposition

A few decades ago, pharmaceutical giants did most of the discovery work in-house, along with every other work necessary to get a drug or medical device to market. Nowadays, nearly …

Continue ›››

[Interview] How D-Wave Brings Quantum Computing Into Biology

In its 2020 Tech Trends report, CB Insights has profiled the 14 tech trends that it considers deserving attention in 2020 and beyond -- quantum computing being on the list. …

Continue ›››

[Interview] This Company Brings Quantum Tech Into Protein Design

With several decades of advances in quantum theory and simultaneous progress in a number of software and hardware fields, we are finally entering the era of quantum computers becoming a …

Continue ›››

[Interview] A Company on the Cutting Edge of COVID-19 Vaccine Development

Recently, COVAXX announced it would soon enter human trials as the company is focused on rapidly developing a Multitope Peptide-based Vaccine (MPV) against SARS-CoV-2. While the biotech industry is now …

Continue ›››

[Interview] A New Way To Work With Data In Life Sciences

Founded by renowned database researcher, Turing Award laureate MIT Professor Michael Stonebraker, Paradigm4 is not just any data analytics company in the Life Sciences. The organization is built on the …

Continue ›››

[Interview] Expediting Drug Discovery Through Advanced Machine Learning

The application of next-generation data analytics tools, powered by machine learning and artificial intelligence (AI) components, has become a long-term strategic priority for most companies in the pharmaceutical and biotech …

Continue ›››

Clinical Research, Artificial Intelligence, and COVID-19

How life sciences companies are reimagining trials during the biggest health crisis in a century Whatever the world was like on March 15, it’s not like that now — and …

Continue ›››

[Interview] Shaping European AI Regulation To Secure Global Leadership In Healthcare

While the history of Artificial Intelligence (AI) field began in the distant 1950s, its practical value had largely remained limited all the way until the emergence of powerful hardware (GPUs) …

Continue ›››

How To Be Ready For Future Pandemics?

What do antibiotic-resistant bacteria (“superbugs”) and coronaviruses have in common? They both can kill lots of people globally, and they both have been commercially unattractive targets for the pharma business …

Continue ›››